Laboratorios Farmaceuticos Financials
| ROVI Stock | EUR 52.30 0.35 0.67% |
Laboratorios |
Please note, the presentation of Laboratorios Farmaceuticos' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Laboratorios Farmaceuticos' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Laboratorios Farmaceuticos' management manipulating its earnings.
Laboratorios Farmaceuticos Stock Summary
Laboratorios Farmaceuticos competes with Fluidra, Almirall, Grifols SA, Pharma Mar, and Solaria Energa. Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. Laboratorios Farmaceticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L. LABORATORIOS FARMACEUTICOS operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1499 people.| Foreign Associate | USA |
| Instrument | Spain Stock View All |
| Exchange | Madrid Exchange |
| ISIN | ES0157261019 |
| Business Address | Calle Jos Isbert, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.rovi.es |
| Phone | 34 91 021 30 00 |
| Currency | EUR - Euro |
You should never invest in Laboratorios Farmaceuticos without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Laboratorios Stock, because this is throwing your money away. Analyzing the key information contained in Laboratorios Farmaceuticos' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Laboratorios Farmaceuticos Key Financial Ratios
Laboratorios Farmaceuticos' financial ratios allow both analysts and investors to convert raw data from Laboratorios Farmaceuticos' financial statements into concise, actionable information that can be used to evaluate the performance of Laboratorios Farmaceuticos over time and compare it to other companies across industries.| Return On Equity | 0.39 | |||
| Return On Asset | 0.18 | |||
| Target Price | 68.09 | |||
| Beta | 0.47 | |||
| Z Score | 23.4 |
Laboratorios Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Laboratorios Farmaceuticos's current stock value. Our valuation model uses many indicators to compare Laboratorios Farmaceuticos value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Laboratorios Farmaceuticos competition to find correlations between indicators driving Laboratorios Farmaceuticos's intrinsic value. More Info.Laboratorios Farmaceuticos ROVI is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.47 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Laboratorios Farmaceuticos ROVI is roughly 2.13 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Laboratorios Farmaceuticos by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Laboratorios Farmaceuticos' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Laboratorios Farmaceuticos Systematic Risk
Laboratorios Farmaceuticos' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Laboratorios Farmaceuticos volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Laboratorios Farmaceuticos correlated with the market. If Beta is less than 0 Laboratorios Farmaceuticos generally moves in the opposite direction as compared to the market. If Laboratorios Farmaceuticos Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Laboratorios Farmaceuticos is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Laboratorios Farmaceuticos is generally in the same direction as the market. If Beta > 1 Laboratorios Farmaceuticos moves generally in the same direction as, but more than the movement of the benchmark.
Laboratorios Farmaceuticos March 28, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Laboratorios Farmaceuticos help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Laboratorios Farmaceuticos ROVI. We use our internally-developed statistical techniques to arrive at the intrinsic value of Laboratorios Farmaceuticos ROVI based on widely used predictive technical indicators. In general, we focus on analyzing Laboratorios Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Laboratorios Farmaceuticos's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 18.44 | |||
| Value At Risk | (2.07) | |||
| Potential Upside | 1.94 |
Complementary Tools for Laboratorios Stock analysis
When running Laboratorios Farmaceuticos' price analysis, check to measure Laboratorios Farmaceuticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorios Farmaceuticos is operating at the current time. Most of Laboratorios Farmaceuticos' value examination focuses on studying past and present price action to predict the probability of Laboratorios Farmaceuticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorios Farmaceuticos' price. Additionally, you may evaluate how the addition of Laboratorios Farmaceuticos to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |